205 related articles for article (PubMed ID: 29029497)
1. Kras mutation is a marker of worse oncologic outcomes after percutaneous radiofrequency ablation of colorectal liver metastases.
Shady W; Petre EN; Vakiani E; Ziv E; Gonen M; Brown KT; Kemeny NE; Solomon SB; Solit DB; Sofocleous CT
Oncotarget; 2017 Sep; 8(39):66117-66127. PubMed ID: 29029497
[TBL] [Abstract][Full Text] [Related]
2. The value of KRAS gene status in predicting local tumor progression of colorectal liver metastases following radiofrequency ablation.
Jiang BB; Yan K; Zhang ZY; Yang W; Wu W; Yin SS; Chen MH
Int J Hyperthermia; 2019 Jan; 36(1):211-219. PubMed ID: 30663903
[TBL] [Abstract][Full Text] [Related]
3. A Single-Center Retrospective Analysis of Periprocedural Variables Affecting Local Tumor Progression after Radiofrequency Ablation of Colorectal Cancer Liver Metastases.
Han K; Kim JH; Yang SG; Park SH; Choi HK; Chun SY; Kim PN; Park J; Lee M
Radiology; 2021 Jan; 298(1):212-218. PubMed ID: 33170105
[TBL] [Abstract][Full Text] [Related]
4. Margin size is an independent predictor of local tumor progression after ablation of colon cancer liver metastases.
Wang X; Sofocleous CT; Erinjeri JP; Petre EN; Gonen M; Do KG; Brown KT; Covey AM; Brody LA; Alago W; Thornton RH; Kemeny NE; Solomon SB
Cardiovasc Intervent Radiol; 2013 Feb; 36(1):166-75. PubMed ID: 22535243
[TBL] [Abstract][Full Text] [Related]
5. Ablation of colorectal liver metastasis: Interaction of ablation margins and RAS mutation profiling on local tumour progression-free survival.
Calandri M; Yamashita S; Gazzera C; Fonio P; Veltri A; Bustreo S; Sheth RA; Yevich SM; Vauthey JN; Odisio BC
Eur Radiol; 2018 Jul; 28(7):2727-2734. PubMed ID: 29417253
[TBL] [Abstract][Full Text] [Related]
6. Impact of Systemic Therapy and Recurrence Pattern on Survival Outcome after Radiofrequency Ablation for Colorectal Liver Metastases.
Stang A; Donati M; Weilert H; Oldhafer KJ
J Cancer; 2016; 7(14):1939-1949. PubMed ID: 27877209
[No Abstract] [Full Text] [Related]
7. Treatment of pulmonary colorectal metastases by radiofrequency ablation.
Petre EN; Jia X; Thornton RH; Sofocleous CT; Alago W; Kemeny NE; Solomon SB
Clin Colorectal Cancer; 2013 Mar; 12(1):37-44. PubMed ID: 23026111
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of percutaneous and open approach to radiofrequency ablation of colorectal liver metastases in Teaching Hospital Pilsen in 20012015].
Brůha J; Liška V; Pálek R; Mírka H; Hošek P; Korčáková E; Bajcurová K; Fichtl J; Skalický T; Třeška V
Rozhl Chir; 2016 Mar; 95(3):107-11. PubMed ID: 27091618
[TBL] [Abstract][Full Text] [Related]
9. Is percutaneous destruction of a solitary liver colorectal metastasis as effective as a resection?
Marchese U; Seux H; Garnier J; Ewald J; Piana G; Lelong B; Chaisemartin C; Meillat H; Delpero JR; Turrini O
Ann Hepatobiliary Pancreat Surg; 2021 May; 25(2):198-205. PubMed ID: 34053922
[TBL] [Abstract][Full Text] [Related]
10. [Prognostic analysis of colorectal liver metastases treated by surgery combined with intraoperative radiofrequency ablation].
Mao R; Zhao JJ; Bi XY; Zhao H; Li ZY; Huang Z; Zhang YF; Chen X; Hu HJ; Wu XL; Hu XH; Cai JQ
Zhonghua Wai Ke Za Zhi; 2017 Jul; 55(7):521-527. PubMed ID: 28655081
[No Abstract] [Full Text] [Related]
11. Patterns of recurrence following selective intraoperative radiofrequency ablation as an adjunct to hepatic resection for colorectal liver metastases.
Eltawil KM; Boame N; Mimeault R; Shabana W; Balaa FK; Jonker DJ; Asmis TR; Martel G
J Surg Oncol; 2014 Nov; 110(6):734-8. PubMed ID: 24965163
[TBL] [Abstract][Full Text] [Related]
12. Lymphocyte-to-monocyte ratio predicts survival after radiofrequency ablation for colorectal liver metastases.
Facciorusso A; Del Prete V; Crucinio N; Serviddio G; Vendemiale G; Muscatiello N
World J Gastroenterol; 2016 Apr; 22(16):4211-8. PubMed ID: 27122671
[TBL] [Abstract][Full Text] [Related]
13. Multi-institutional analysis of outcomes for thermosphere microwave ablation treatment of colorectal liver metastases: the SMAC study.
De Cobelli F; Calandri M; Della Corte A; Sirovich R; Gazzera C; Della Vigna P; Bonomo G; Varano GM; Maiettini D; Mauri G; Camisassi N; Steidler S; Ratti F; Gusmini S; Ronzoni M; Aldrighetti L; Odisio BC; Racca P; Fonio P; Veltri A; Orsi F
Eur Radiol; 2022 Jun; 32(6):4147-4159. PubMed ID: 35092474
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous radiofrequency ablation of solitary hepatic metastases from colorectal cancer: risk factors of local tumor progression-free survival and overall survival.
Lee HJ; Lee MW; Ahn SH; Cha DI; Ko SE; Kang TW; Song KD; Rhim H
Ultrasonography; 2022 Oct; 41(4):728-739. PubMed ID: 35909318
[TBL] [Abstract][Full Text] [Related]
15. Local recurrence rates after radiofrequency ablation or resection of colorectal liver metastases. Analysis of the European Organisation for Research and Treatment of Cancer #40004 and #40983.
Tanis E; Nordlinger B; Mauer M; Sorbye H; van Coevorden F; Gruenberger T; Schlag PM; Punt CJ; Ledermann J; Ruers TJ
Eur J Cancer; 2014 Mar; 50(5):912-9. PubMed ID: 24411080
[TBL] [Abstract][Full Text] [Related]
16. Oncological outcomes and predictors of radiofrequency ablation of colorectal cancer liver metastases.
Wang CZ; Yan GX; Xin H; Liu ZY
World J Gastrointest Oncol; 2020 Sep; 12(9):1044-1055. PubMed ID: 33005297
[TBL] [Abstract][Full Text] [Related]
17. Thermal Ablation in the Management of Colorectal Cancer Patients with Oligometastatic Liver Disease.
Petre EN; Sofocleous C
Visc Med; 2017 Mar; 33(1):62-68. PubMed ID: 28612019
[TBL] [Abstract][Full Text] [Related]
18. Potential for cure and predictors of long-term survival after radiofrequency ablation for colorectal liver metastases: A 20-years single-center experience.
Weilert H; Sadeghi D; Lipp M; Oldhafer KJ; Donati M; Stang A
Eur J Surg Oncol; 2022 Dec; 48(12):2487-2494. PubMed ID: 35718675
[TBL] [Abstract][Full Text] [Related]
19. A new sequential treatment strategy for multiple colorectal liver metastases: Planned incomplete resection and postoperative completion ablation for intentionally-untreated tumors under guidance of cross-sectional imaging.
Okuno M; Kawaguchi Y; De Bellis M; Vega EA; Huang SY; Ahrar K; Gupta S; Vauthey JN; Odisio BC
Eur J Surg Oncol; 2021 Feb; 47(2):311-316. PubMed ID: 32873452
[TBL] [Abstract][Full Text] [Related]
20. Lung Adenocarcinoma: Predictive Value of KRAS Mutation Status in Assessing Local Recurrence in Patients Undergoing Image-guided Ablation.
Ziv E; Erinjeri JP; Yarmohammadi H; Boas FE; Petre EN; Gao S; Shady W; Sofocleous CT; Jones DR; Rudin CM; Solomon SB
Radiology; 2017 Jan; 282(1):251-258. PubMed ID: 27440441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
